RUN Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
Sunrun Inc (RUN) is not a good buy for a beginner investor with a long-term strategy at this time. The stock is facing significant challenges, including a negative technical trend, cautious analyst sentiment, and declining financial performance. While there are some positive catalysts, such as revenue growth and improving gross margins, these are overshadowed by declining net income, EPS, and a pessimistic outlook for 2026. Additionally, the lack of strong proprietary trading signals and the absence of recent congress trading data further reduce confidence in the stock as a viable investment option.
The technical indicators for RUN are bearish. The MACD histogram is negative (-0.918), RSI is at 19.22, indicating an oversold condition, and moving averages are converging. The stock is trading near its support level (S1: 12.322) with a potential drop to S2: 10.195. Overall, the technical trend suggests weakness.
Revenue increased by 123.50% YoY in Q4 2025, reaching $1.16 billion.
Gross margin improved significantly to 37.57%, up 99.84% YoY.
Increasing storage attach rates and in-house installation efficiency improvements are promising for long-term operational efficiency.
Net income dropped by -103.68% YoY, and EPS fell by -103.01% YoY in Q4
Analysts have downgraded the stock and reduced price targets, citing overvaluation and a cautious 2026 outlook.
The company is under investigation for potential securities fraud, and the solar industry is facing policy challenges and rising costs.
The stock has dropped significantly, with a 35.11% decline following weak Q4 2025 metrics.
In Q4 2025, Sunrun reported a 123.50% YoY increase in revenue to $1.16 billion. However, net income dropped by -103.68% YoY, and EPS fell by -103.01% YoY. Gross margin improved to 37.57%, up 99.84% YoY, but the overall financial performance indicates declining profitability and a cautious outlook for 2026.
Analyst sentiment is predominantly negative. Multiple firms have downgraded the stock, citing overvaluation and a cautious growth outlook for 2026. Price targets have been lowered significantly, with some as low as $6.73. While a few analysts maintain an Outperform rating, the majority view the stock as a Hold or Sell.
